Mazen W. Karaman

A quantitative analysis of kinase inhibitor selectivity

Mazen W. Karaman, Sanna Herrgård, Daniel K. Treiber et al. · Nature Biotechnology · 2008 · 2.4K citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

Patrick P. Zarrinkar, Ruwanthi N. Gunawardane, Merryl Cramer et al. · Blood · 2009 · 644 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Mutation and genomic deletion status of <i>ataxia telangiectasia mutated</i> ( <i>ATM</i> ) and <i>p53</i> confer specific gene expression profiles in mantle cell lymphoma

Timothy C. Greiner, Chiranjib Dasgupta, Vincent V. Ho et al. · Proceedings of the National Academy of Sciences · 2006 · 151 citations · Full text

Life Sciences, Genetics, Oncology +17

Comparative Analysis of Gene-Expression Patterns in Human and African Great Ape Cultured Fibroblasts

Mazen W. Karaman, Marlys L. Houck, Leona G. Chemnick et al. · Genome Research · 2003 · 105 citations · Full text

Life Sciences, Biology, Genetics +12

Motexafin Gadolinium and Zinc Induce Oxidative Stress Responses and Apoptosis in B-Cell Lymphoma Lines

Philip Lecane, Mazen W. Karaman, Mint Sirisawad et al. · Cancer Research · 2005 · 75 citations

Life Sciences, Cell Biology, Oncology +15